Xinye Chen

发表

Discovery of precision targeting EZH2 degraders for triple-negative breast cancer.

Shun-Jie Li, Zhongwen Luo, Yonglei Zhang, 2022, European journal of medicinal chemistry.

Design, synthesis and biological evaluation of N-phenylquinazolin-4-amine hybrids as dual inhibitors of VEGFR-2 and HDAC.

Ting-Ting Wu, Jia-Yu Xue, Yun-Gen Xu, 2016, European journal of medicinal chemistry.